The chances of surviving childhood cancer are better than ever before. While most survivors enjoy good health after their cure, some develop "late effects," which are chronic medical conditions or emotional difficulties that appear years after treatment.
Cleveland Clinic Children's High-Five Cancer Survivor’s Clinic is a long-term follow-up clinic for children and adults who have reached the point of five years from their diagnosis of pediatric cancer and have been off therapy for at least three years. We also work with patients who have been treated for non-cancerous diseases with chemotherapy, radiation therapy or stem cell transplant.
Our specially trained team works with many different subspecialties to provide individualized care tailored specifically for childhood cancer survivors. In addition, we work with our patients' primary care physicians to make them aware of any issues that may need close monitoring.
Counseling and educating childhood cancer patients who are in the process of undergoing cancer therapy, as well as their families, about "late effects" and the importance of post-therapy follow-up care are important aspects of our Clinic. We help ensure our patients' success by identifying and managing their medical conditions and emotional needs. Our goal is to help childhood cancer survivors move forward confidently with their lives by arming them with the information they need to preserve their health.
Who We Treat
The High-Five Cancer Survivor’s Clinic team also counsels childhood cancer patients who are in the process of undergoing cancer therapy, as well as their families, to educate them about late effects and the importance of post-therapy follow-up care. In addition, we also work with those who have been treated for non-cancer diseases with chemotherapy, radiation therapy or stem cell transplant.
We help ensure survivor success by identifying and managing late effects in survivors. The professionals within the clinic help patients move forward confidently with their lives, armed with the information they need to preserve their health.
What We Look For
Late effects can be a result of surgery, chemotherapy, radiation and blood and marrow or stem cell transplants. The effects vary depending upon the type of cancer or noncancerous disease, the course of treatment and quite possibly the age of the child during treatment, among other things. Some examples of late effects are:
- Secondary cancers
- Early menopause
- Heart damage, including premature coronary artery disease
- Neuropsychological effects, such as learning disabilities
- Psychosocial issues like decreased self-esteem and stress
- Pulmonary toxicity
- Hormonal and growth disorders
- Genitourinary problems
- Gastrointestinal effects
Pediatric Hematology/Oncology Team
- Seth Rotz, MD, Medical Director
- Jennifer Weaver, RN
Childhood and young adult cancer survivors are a unique population of patients. Our team partners with both pediatric and adult subspecialists to help address a variety of issues that can occur.
- Allison Himes, BS
- Gautam Mankaney, MD
- Harry Adrian Lesmana, MD, CGC
- Brittany Griffin, MS, CGC, PhD
- Sara Bewley, MS, RD, CSP, LD
Physical Medicine and Rehabilitation
- Laine Holman, MD
- Taylor Buss, MSW, LSW
We can also help provide the following resources:
- Occupational or physical therapy
- Vocational Rehab
- Education Resources
- 504 Plan
ALTE11C1. Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas.
ALTE1631. Web-based Exercise Study for Children and Adolescents with Acute Lymphoblastic Leukemia
ALTE07C1. Neuropsychological and Behavioral Testing in Younger Patients With Cancer.
ALTE16C1. Effects of Modern Chemotherapy Regimens on Spermatogenesis and Steroidogenesis in Adolescent and Young Adult (AYA) Survivors of Osteosarcoma.
Long-term systolic function in children and young adults after hematopoietic stem cell transplant. Rotz SJ, Dandoy CE, Taylor MD, Jodele S, Jefferies JL, Lane A, El-Bietar JA, Powell AW, Davies SM, Ryan TD. Bone Marrow Transplant. 2017 Jul 17. doi: 10.1038/bmt.2017.162. [Epub ahead of print] PMID:28714947
Cardiotoxicity and cardiomyopathy in children and young adult survivors of hematopoietic stem cell transplant. Rotz SJ, Ryan TD, Hlavaty J, George SA, El-Bietar J, Dandoy CE. Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26600. Epub 2017 Apr 28. Review. PMID:28453909
The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults. Rotz SJ, Ryan TD, Jodele S, Jefferies JL, Lane A, Pate A, Hirsch R, Hlavaty J, Levesque AE, Taylor MD, Cash M, Myers KC, El-Bietar JA, Davies SM, Dandoy CE. Bone Marrow Transplant. 2017 Aug;52(8):1171-1179. doi: 10.1038/bmt.2017.62. Epub 2017 Apr 10
Pulmonary hypertension associated with bronchiolitis obliterans after hematopoietic stem cell transplantation. Pate A, Rotz S, Warren M, Hirsch R, Cash M, Myers KC, El-Bietar J, Nelson A, Wallace G, Filipovich AH, Bleesing J, Chima RS, Davies SM, Jodele S, Dandoy CE. Bone Marrow Transplant. 2016 Feb;51(2):310-2. doi: 10.1038/bmt.2015.248. Epub 2015 Oct 19. No abstract available. PMID:26479977
Cerebral vascular abnormalities in pediatric patients with sickle cell disease after hematopoietic cell transplant. Bodas P, Rotz S. J Pediatr Hematol Oncol. 2014 Apr;36(3):190-3. doi: 10.1097/MPH.0000000000000089. Review. PMID:24327127
*A new browser window will open with this link.
The inclusion of links to other websites does not imply any endorsement of the material on those websites nor any association with their operators.
If you or your child is a survivor of childhood cancer, treated anywhere, and you have any questions or would like to make a virtual or in-person appointment, please contact Jen Weaver at 216.444.1216 or email@example.com.